Chief Market Strategist
Ross Givens is a veteran trader with over 15 years of experience and a former VP at a major Wall Street investment bank. Specializing in small-cap stocks and momentum-driven plays, Ross identifies high-probability setups before they hit the mainstream. As Lead Strategist at Traders Agency, he has guided hundreds of successful trades and developed multiple flagship publications.
Trading the markets is never easy. “Mr. Market” is out to fool as many investors as possible on a daily basis… Especially traders who are new to the game and aren’t quite sure what to watch out for. This is why having a trading plan is absolutely crucial to your long-term success. Personally, I look … Continue reading “How to Use Volume as Part of Your Stock Strategy” The post How to Use Volume as Part of Your Stock Strategy appeared first on Stock Surge Daily.
Last Thursday, I told you about Oramed Pharmaceuticals Inc. (ORMP)… This Watchlist stock was up nearly 30% in only three days from our entry trigger. But that’s not the only Stock Surge Daily idea that has worked lately. In fact, two stocks from this week’s Watchlist are already up nicely. Shares of TechTarget, Inc. (TTGT), … Continue reading “When Having a Good Plan Pays Off” The post When Having a Good Plan Pays Off appeared first on Stock Surge Daily.
I’ve talked before about The 4 Stages of the Stock Cycle… And why you only want to own stocks during Stage 2 – the accumulation stage. If you want to make money in stocks, this is when you need to own them. But just as important as waiting for a confirmed Stage 2 uptrend to … Continue reading “Why I Don’t Hold Stocks Through This One Stage of the Cycle” The post Why I Don’t Hold Stocks Through This One Stage of the Cycle appeared first on Stock Surge Daily.
TechTarget, Inc. TechTarget, Inc. (TTGT) is an enterprise software company focused on providing intent-driven market and sales data for business-to-business (B2B) companies. Here’s how the chart is setting up: And here’s how the stock is setting up with my Stock Surge Indicator (SSI): Surge score: 88/100 % Above 52-wk low: 103% MFI reading: 72 Sales … Continue reading “Watchlist Week of Nov 8th, 2021” The post Watchlist Week of Nov 8th, 2021 appeared first on Stock Surge Daily.
Market bulls continued to stampede the bearish camp this week as the S&P 500 index notched a huge gain of 2.2% — its largest weekly run since June. The buying has been relentless for the general stock market over the last five weeks, with the gains only accelerating to the upside. This week’s action brings … Continue reading “Watchlist Update: These Stocks Are Set to Move Big” The post Watchlist Update: These Stocks Are Set to Move Big appeared first on Stock Surge Daily.
Still think value investing is the way to go? Consider this… Elon Musk made more money in the last 90 days than Warren Buffett made in the last 90 years! In fact, the Tesla, Inc. (TSLA) CEO is now worth more than Bill Gates and Warren Buffett combined! So how did he do it? Index … Continue reading “How Elon Musk Became the World’s Richest Man” The post How Elon Musk Became the World’s Richest Man appeared first on Stock Surge Daily.
On Monday, I alerted you that three new stocks had been added to my Watchlist for this week. One of those was Oramed Pharmaceuticals Inc. (ORMP). And I sure hope you got involved with this trade idea… This is a pharmaceutical company focused on the development of oral drug delivery systems – most notably, insulin … Continue reading “This Watchlist Stock is Up 28% in Just Three Days” The post This Watchlist Stock is Up 28% in Just Three Days appeared first on Stock Surge Daily.
Paul Tudor Jones is one of the greatest traders who ever lived. In 1987, he predicted the Black Monday crash and tripled his money in a single day – earning an estimated $100 million. His success has continued for more than three decades. Today, the hedge fund titan has a net worth of $5.3 billion. … Continue reading “Why Only Losers Average Down on Losing Trades” The post Why Only Losers Average Down on Losing Trades appeared first on Stock Surge Daily.
Facebook has had its fair share of problems recently… So, the company is rebranding. Going forward, the company will be known as Meta Platforms, Inc. (FB) – a signal of CEO Mark Zuckerberg’s intention to own and operate the “metaverse.” And starting Dec. 1, the ticker will change from FB to MVRS. Zuckerberg has not … Continue reading “Why Mark Zuckerberg Wants to Own the Metaverse” The post Why Mark Zuckerberg Wants to Own the Metaverse appeared first on Stock Surge Daily.
Oramed Pharmaceuticals Inc. Oramed Pharmaceuticals Inc. (ORMP) is a pharmaceutical company focused on the development of oral drug delivery systems – most notably, insulin capsules for the treatment of type 2 diabetes. This is an exciting development for the medical community and anyone required to inject themselves with insulin. On Friday, the company announced that … Continue reading “Watchlist Week of Nov 1st, 2021” The post Watchlist Week of Nov 1st, 2021 appeared first on Stock Surge Daily.
While Friday’s session ended relatively flat, last week was another one for the record books. The S&P 500 ended the week higher by 1.3% and set a new all-time high of 4,608.08, while the Nasdaq 100 jumped 3.2% to set its own all-time high of 15,504.12. That’s largely thanks to the strong earnings reports we … Continue reading “The Small-Cap Surge Stocks You Need to Know About” The post The Small-Cap Surge Stocks You Need to Know About appeared first on Stock Surge Daily.
By now, you’ve likely seen the news… Former President Donald Trump is jumping into the special purpose acquisition company (SPAC) craze. Trump is planning to take his new social media venture, TRUTH Social, public through a merger agreement between Trump Media & Technology Group (TMTG) and Digital World Acquisition Corp. (DWAC). According to a press … Continue reading “How Donald Trump is Crushing Social Media Stocks” The post How Donald Trump is Crushing Social Media Stocks appeared first on Stock Surge Daily.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.